Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amryt Pharma (AMYT)
NASDAQ:AMYT
Holding AMYT?
Track your performance easily
AMYT Stock Chart & Stats
Day’s Range$14.63 - $14.76
52-Week Range― - ―
Previous Close$14.69
Volume2.39M
Average Volume (3M)N/A
Market Cap
$937.05M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Amryt Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMYT FAQ
What was Amryt Pharma’s price range in the past 12 months?
Currently, no data Available
What is Amryt Pharma’s market cap?
Currently, no data Available
When is Amryt Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Amryt Pharma’s earnings last quarter?
Currently, no data Available
Is Amryt Pharma overvalued?
According to Wall Street analysts Amryt Pharma’s price is currently Overvalued.
Does Amryt Pharma pay dividends?
Amryt Pharma does not currently pay dividends.
What is Amryt Pharma’s EPS estimate?
Amryt Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amryt Pharma have?
Currently, no data Available
What happened to Amryt Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Amryt Pharma?
Among the largest hedge funds holding Amryt Pharma’s share is Highbridge Capital Management LLC. It holds Amryt Pharma’s shares valued at 92M.
---
Amryt Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Amryt Pharma
Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).
---
AMYT Stock 12 Month Forecast
Average Price Target
―---